Mr. Michal Efraty reports

NEUROTHERA LABS ENGAGES BULLVESTOR FOR INVESTOR RELATIONS ACTIVITIES

Neurothera Labs Inc. has engaged bullVestor Median GmbH pursuant to an investor relations agreement dated April 23, 2026, for assistance with its investor awareness marketing campaign.

bullVestor provides marketing and investor relations services and will assist the company in enhancing its visibility with potential investors by providing, among other services, content creation management, keyword optimization, ad groups and display ads, project management, and media distribution for a total cost of 300,000 euros for a six-month period commencing on or about the date on which the TSX Venture Exchange approves the engagement. Pursuant to the agreement respecting the engagement, 150,000 euros are payable within seven days following the date of the TSX-V approval, with the remaining 150,000 euros being payable within 45 days following the date of the TSX-V approval. bullVestor is an arm's-length party from the company and principally operates out of Austria. As of the date of this press release, to the knowledge of the company, neither bullVestor nor any of its directors and officers own any interest, directly or indirectly, in the securities of the company. bullVestor's engagement is subject to approval of the TSX-V.

About Neurothera Labs Inc.

Neurothera is a clinical-stage pharmaceutical company focused on developing novel therapeutics for central nervous system disorders and other underserved health conditions through collaborations and innovative combinations.

We seek Safe Harbor.